(Q24306910)

English

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation

scientific article

Statements

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation (English)
0 references
0 references
0 references
0 references
Ke Liang
0 references
Francisco J Esteva
0 references
Constance Albarracin
0 references
Katherine Stemke-Hale
0 references
Yang Lu
0 references
Giampaolo Bianchini
0 references
Ching-Yi Yang
0 references
Yong Li
0 references
Xinqun Li
0 references
Chun-Te Chen
0 references
John Mendelsohn
0 references
Zhen Fan
0 references
16 November 2010
0 references
0 references
18
0 references
423-35
0 references
5
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit